Brief: Genocea Biosciences Inc QTRLY Loss Per Share $0.05
02/08/2018 13:18
Genocea Biosciences Inc GNCA.O :
* GENOCEA REPORTS SECOND QUARTER 2018 FINANCIAL AND
OPERATING
RESULTS
* GENOCEA BIOSCIENCES INC QTRLY LOSS PER SHARE $0.05
* GENOCEA BIOSCIENCES - EXPECT EXISTING CASH & CASH
EQUIVALENTS
SUFFICIENT TO SUPPORT OPERATING EXPENSES & CAPEX NEEDS INTO Q4
2019
* GENOCEA BIOSCIENCES INC - CONTINUES TO EXPLORE STRATEGIC
ALTERNATIVES FOR GEN-003
Source text for Eikon: ID:nGNX3PT9WL
Further company coverage: GNCA.O
Recent news on Genocea Biosciences
See all newsBluebird, Chimerix, Clovis have under 6 months of cash left - Truist
Genocea Biosciences plunges as it winds down operations
Brief: Genocea Announces Wind Down Of Operations And Delisting From Nasdaq
Genocea Biosciences Inc reports results for the quarter ended in March - Earnings Summary
U.S. STOCKS ON THE MOVE-Oppenheimer Holdings, IES Holdings Inc, Avantor Inc